MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Operating income, 2025
- −$22M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$22M | — |
| 2024 | −$88M | — |
| 2023 | −$109M | — |
| 2022 | −$131M | — |
| 2021 | −$173M | — |
| 2020 | −$104M | — |
| 2019 | −$55M | — |